Related references
Note: Only part of the references are listed.3D image texture analysis of simulated and real-world vascular trees
Marek Kocinski et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2012)
Three-dimensional quantification of capillary networks in healthy and cancerous tissues of two mice
Sabrina Lang et al.
MICROVASCULAR RESEARCH (2012)
Enhanced anti-tumor activity by the combination of TRAIL/Apo-2L and combretastatin A-4 against human colon cancer cells via induction of apoptosis in vitro and in vivo
Chong Zhang et al.
CANCER LETTERS (2011)
An automatic algorithm for the segmentation and morphological analysis of microvessels in immunostained histological tumour sections
C. C. Reyes-Aldasoro et al.
JOURNAL OF MICROSCOPY (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Rapid Analysis of Vessel Elements (RAVE): A Tool for Studying Physiologic, Pathologic and Tumor Angiogenesis
Marc E. Seaman et al.
PLOS ONE (2011)
A Computational Tool for Quantitative Analysis of Vascular Networks
Enrique Zudaire et al.
PLOS ONE (2011)
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature
Cristiana Lavazza et al.
BLOOD (2010)
Disrupting Established Tumor Blood Vessels An Emerging Therapeutic Strategy for Cancer
Mark J. McKeage et al.
CANCER (2010)
Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
Dan Huang et al.
CANCER RESEARCH (2010)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments
Marco Righi et al.
LABORATORY INVESTIGATION (2009)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Revacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy
Paxton V. Dickson et al.
CLINICAL CANCER RESEARCH (2007)
Sunitinib: From rational design to clinical efficacy
Laura Q. M. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
Blood vessel staining in the myocardium for 3D visualization down to the smallest capillaries
B Müller et al.
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS (2006)
Pericytes limit tumor cell metastasis
XJ Xian et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
3-D quantification and visualization of vascular structures from confocal microscopic images using skeletonization and voxel-coding
H Soltanian-Zadeh et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2005)
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature
JN Rybak et al.
NATURE METHODS (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
X-ray high-resolution vascular network imaging
F Plouraboué et al.
JOURNAL OF MICROSCOPY-OXFORD (2004)
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors
RT Tong et al.
CANCER RESEARCH (2004)
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
AM O'Farrell et al.
BLOOD (2003)
Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase
L Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Quantitative evaluation of convolution-based methods for medical image interpolation
EHW Meijering et al.
MEDICAL IMAGE ANALYSIS (2001)
Share Paper
